ANVS PR: https://www.globenewswire.com/news-release/2024/07/02/2907365/0/en/Annovis-Bio-Announces-New-Data-from-Phase-III-Parkinson-s-Study-Highlighting-Improvements-in-Unified-Parkinson-s-Disease-Rating-Scale-MDS-UPDRS-and-Cognition-after-Treatment-with-B.html Caveat emptor. The above PR contains post hoc subgroup analysis.